Ottosson NE , Wu X , Nolting A , Karlsson U , Lund PE , Ruda K , Svensson S , Konradsson P , Elinder F .

	Figure 1. The effect of several natural resin acids on the opening of the Shaker K channel.(a) Molecular structure (from left to right) for pimaric acid (PiMA) (1), isopimaric acid (Iso-PiMA) (2), abietic acid (AA) (3), dehydroabietic acid (DHAA) (4), and podocarpic acid (PoCA) (5). (b) Representative current traces for voltages corresponding to 10% of maximum conductance in control solution at pH 7.4 of the 3R Shaker K channel. Black traces indicate control, and red traces 100 μM compound (same order as in a). (c) Representative G(V) curves for DHAA effects, same cell as in b (control, black symbols; DHAA, red symbols. ∆VG(V) = −15.5. (d) Ring nomenclature of the general compound skeleton (blue) and modified carbons in derivates (grey). (e) Gating charge residues (362 = R1, and 365 = R2) and mutated residues (shown as R) of the 3R Shaker K channel (359R, and 356R) are marked on one VSD of the Shaker K channel in the active state. (f) Compound-induced G(V) shifts for the WT (blue) and 3R Shaker K channel (red). Mean ± SEM (n = 9, 15, 15, 6, 4, 4, 5, 5, 10, 6, 4, and 6 from left to right). Data for DHA (6) and PiMA (1) are from ref 17. The shifts of WT and 3R Shaker K channel are compared for each compound (one-way ANOVA together with Bonferroni’s multiple comparison test: *P < 0.05; ***P < 0.0001).
	Figure 2. The effect of modifications of C7 at the B-ring for the activation of the 3R Shaker K channel.Chemical side chain and molecular structure for the introduced side chain at C7 of DHAA (4) (middle) for the specific compound (left). Compound(100 μM)-induced G(V) shifts for the 3R Shaker K channel (right). The dashed line equals the DHAA-induced shift. Mean ± SEM (n = 4–6). The shifts are compared with DHAA (4) (one-way ANOVA together with Dunnett’s multiple comparison test: *P < 0.05; **P < 0.01; ***P < 0.001).
	Figure 3. Halogenation-dependent potency.Shift of G(V) (mean values) by the unhalogenated and halogenated DHAA (4) derivates (100 μM), arranged according to halogenation of the C-ring (horizontal) and side chains attached to C7 (vertical). Compounds are color coded according to their potency: dark green: ∆VG(V) ≤ −30.0 mV, green: −30.0 mV < ∆VG(V) ≤ −25.0 mV, light green: −25.0 mV < ∆VG(V) ≤ −20.0 mV, yellow: −20.0 mV < ∆VG(V) ≤ −15.0 mV, orange: −15.0 mV < ∆VG(V) ≤ −10.0 mV, light red: −10.0 mV < ∆VG(V) ≤ −5 mV, red: −5.0 mV < ∆VG(V) ≤ 0.0 mV, dark red: ∆VG(V) > +0.0 mV.
	Figure 4. Replacement of the isopropyl group at C13 with a chlorine.(a) Molecular structure for Compound 67 (upper) and Compound 77 (lower). (b) Representative current traces for voltages corresponding to 10% of maximum conductance in control solution at pH 7.4 of the 3R Shaker K channel. Black traces indicate control, and red traces 100 μM compound (upper, Compound 67; lower, Compound 77). (c) Representative G(V) curves. Same cells as in b (control, black symbols; compound, red symbols. ∆VG(V) = −6.1 mV by Compound 67 (upper), and −32.6 mV by Compound 77 (lower) in these examples.
	Figure 5. Concentration and pH dependent compound effects.(a) Concentration response curve for DHAA (4) (grey), Compound 33 (red), and Compound 77 (blue) at pH 7.4 for the 3R Shaker K channel. Error bars indicate SEM (n = 4–9). (b) Compound-induced G(V) shifts for the WT and 3R Shaker K channels. (c,d) pH dependence curves for WT (c) and 3R Shaker K channel (d) for 100 μM DHAA (4) (grey), 100 μM Compound 33 (red), and 100 μM Compound 77 (blue). Error bars indicate SEM (n = 4–9).
	Figure 6. The effect of compounds on the resting membrane potential (Vm) and excitability of DRG neurons.(a) Recordings of Vm during application of Compound 13 and 77. (b) Compound-induced hyperpolarizing shifts of Vm of DRGs (10 μM at pH 7.4) plotted versus the shifts for the 3R Shaker K channel expressed in Xenopus oocytes (100 μM at pH 7.4). Mean ± SEM (for DRG-recordings, n = 4–7; for oocyte recordings, n = 4–9). (c) Effects on single action potentials by Compound 13 and 77 (black is control and red is test compound). (d) Effects on repetitive firing elicited by a continuous current pulse. The effect of Compound 77 is clearly reversible. Compound 13 had almost no effect.

Börjesson, An electrostatic potassium channel opener targeting the final voltage sensor transition. 2011, Pubmed, Xenbase

Börjesson, An electrostatic potassium channel opener targeting the final voltage sensor transition. 2011, Pubmed , Xenbase
Börjesson, Lipoelectric modification of ion channel voltage gating by polyunsaturated fatty acids. 2008, Pubmed , Xenbase
Börjesson, Electrostatic tuning of cellular excitability. 2010, Pubmed , Xenbase
Börjesson, Structure, function, and modification of the voltage sensor in voltage-gated ion channels. 2008, Pubmed
Catterall, Ion channel voltage sensors: structure, function, and pathophysiology. 2010, Pubmed
Cui, Novel oxime and oxime ether derivatives of 12,14-dichlorodehydroabietic acid: design, synthesis, and BK channel-opening activity. 2008, Pubmed
Cui, Design, synthesis, and characterization of BK channel openers based on oximation of abietane diterpene derivatives. 2010, Pubmed
Doyle, The structure of the potassium channel: molecular basis of K+ conduction and selectivity. 1998, Pubmed
Gessner, Molecular mechanism of pharmacological activation of BK channels. 2012, Pubmed
Harmer, Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks. 2008, Pubmed
Henrion, Tracking a complete voltage-sensor cycle with metal-ion bridges. 2012, Pubmed , Xenbase
Hille, Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. 1977, Pubmed
Hoshi, Mechanism of the modulation of BK potassium channel complexes with different auxiliary subunit compositions by the omega-3 fatty acid DHA. 2013, Pubmed
Hoshi, Biophysical and molecular mechanisms of Shaker potassium channel inactivation. 1990, Pubmed , Xenbase
Hoshi, Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca²⁺-dependent K⁺ channels. 2013, Pubmed
Ido, Screening quality for Ca2+-activated potassium channel in IonWorks Quattro is greatly improved by using BAPTA-AM and ionomycin. 2013, Pubmed
Imaizumi, Molecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit. 2002, Pubmed
Kamb, Molecular characterization of Shaker, a Drosophila gene that encodes a potassium channel. 1987, Pubmed
Leaf, The antiarrhythmic and anticonvulsant effects of dietary N-3 fatty acids. 1999, Pubmed
Lee, Treatment strategy for the patient with hippocampal sclerosis who failed to the first antiepileptic drug. 2014, Pubmed
Liin, Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel. 2015, Pubmed , Xenbase
Long, Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. 2007, Pubmed
Milescu, Opening the shaker K+ channel with hanatoxin. 2013, Pubmed , Xenbase
Moshé, Epilepsy: new advances. 2015, Pubmed
Ottosson, Drug-induced ion channel opening tuned by the voltage sensor charge profile. 2014, Pubmed , Xenbase
Peretz, Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier. 2010, Pubmed
Rolf, Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes. 2000, Pubmed , Xenbase
Schuele, Intractable epilepsy: management and therapeutic alternatives. 2008, Pubmed
Swartz, Hanatoxin modifies the gating of a voltage-dependent K+ channel through multiple binding sites. 1997, Pubmed , Xenbase
Tashima, Design, synthesis, and BK channel-opening activity of hexahydrodibenzazepinone derivatives. 2006, Pubmed
Tigerholm, Dampening of hyperexcitability in CA1 pyramidal neurons by polyunsaturated fatty acids acting on voltage-gated ion channels. 2012, Pubmed
Tsantoulas, Opening paths to novel analgesics: the role of potassium channels in chronic pain. 2014, Pubmed
Vargas, An emerging consensus on voltage-dependent gating from computational modeling and molecular dynamics simulations. 2012, Pubmed
Wuttke, The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. 2005, Pubmed , Xenbase
Xu, Polyunsaturated fatty acids and cerebrospinal fluid from children on the ketogenic diet open a voltage-gated K channel: a putative mechanism of antiseizure action. 2008, Pubmed , Xenbase
ZEISS, The chemistry of the resin acids. 1948, Pubmed